Events

Symeres will be attending the EFMC International Symposium on Medicinal Chemistry (EFMC-ISMC) 2026, one of Europe's leading conferences for medicinal chemistry and early drug discovery. Bringing together scientists from biotechnology, pharmaceutical, and academic organisations, the symposium provides an opportunity to share scientific advances and build new collaborations. We look forward to discussing how our integrated drug discovery expertise can help accelerate your next therapeutic program.

Symeres will be attending the 56th Organic Process Research & Development (OPR&D) Conference 2026, one of the leading international events dedicated to process chemistry and pharmaceutical development. Bringing together scientists from biotechnology, pharmaceutical, and academic organisations, the conference provides an opportunity to share the latest advances in synthetic route design, process optimisation, scale-up, and manufacturing. We look forward to discussing how our integrated process chemistry, CMC, and manufacturing expertise can help accelerate your drug development program.

Symeres will be attending the DMDG-GMP-SPS Joint Meeting 2026, a leading scientific meeting focused on ADME, DMPK, metabolism, pharmacokinetics, and PK/PD modelling. Bringing together scientists from biotechnology, pharmaceutical, and academic organisations, the meeting provides an opportunity to share scientific advances and build new collaborations. We look forward to discussing how our integrated ADME-Tox and drug discovery expertise can support your next therapeutic program.

Symeres will be attending CPHI Milan 2026, the world's leading pharmaceutical event. Bringing together innovators from across the pharmaceutical supply chain, CPHI provides an opportunity to explore the latest advances in drug discovery, development, manufacturing, and commercialization. We look forward to connecting with biotechnology and pharmaceutical partners to discuss how our integrated scientific capabilities can help accelerate drug development from discovery through to clinical manufacturing.